Unresectable or metastatic urothelial carcinoma
Conditions
Interventions
None listed
Sponsors
Minegishi Toshihiko
Eligibility
Inclusion criteria
Inclusion criteria: 1. Urologists or medical oncologists 2. Physicians who have experience within the past 6 months of administering first-line treatment, excluding best supportive care, to patients with unresectable or recurrent urothelial carcinoma (UC) 3. Physicians who have experience in determining the treatment plan when administering chemotherapy to patients with unresectable or recurrent UC 4. Able to provide informed consent There are other inclusion criteria.
Exclusion criteria
Exclusion criteria: 1. Physicians working in departments other than urology or oncology 2. Physicians working at clinics 3. When the EV-P or gemcitabine-cisplatin plus maintenance avelumab regimen is not registered at the workplace There are other exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The questionnaire will collect data on the demographic characteristics of participating physicians, recent practices regarding first-line treatment for UC patients, and evaluations and expectations concerning available treatment options. | — |
Contacts
Public ContactYuki Suzaki
MSD K.K., Tokyo, Japan
Outcome results
None listed